key: cord-0910899-ok6howbo authors: Ortelli, Paola; Ferrazzoli, Davide; Sebastianelli, Luca; Maestri, Roberto; Dezi, Sabrina; Spampinato, Danny; Saltuari, Leopold; Alibardi, Alessia; Engl, Michael; Kofler, Markus; Quartarone, Angelo; Koch, Giacomo; Oliviero, Antonio; Versace, Viviana title: Altered motor cortex physiology and dysexecutive syndrome in patients with fatigue and cognitive difficulties after mild COVID‐19 date: 2022-02-24 journal: Eur J Neurol DOI: 10.1111/ene.15278 sha: 8d158ac528a65cc909efd7a4aa88dfbbeb4e9eda doc_id: 910899 cord_uid: ok6howbo BACKGROUND AND PURPOSE: Fatigue and cognitive difficulties are reported as the most frequently persistent symptoms in patients after mild SARS‐CoV‐2 infection. An extensive neurophysiological and neuropsychological assessment of such patients was performed focusing on motor cortex physiology and executive cognitive functions. METHODS: Sixty‐seven patients complaining of fatigue and/or cognitive difficulties after resolution of mild SARS‐CoV‐2 infection were enrolled together with 22 healthy controls (HCs). Persistent clinical symptoms were investigated by means of a 16‐item questionnaire. Fatigue, exertion, cognitive difficulties, mood and ‘well‐being’ were evaluated through self‐administered tools. Utilizing transcranial magnetic stimulation of the primary motor cortex (M1) resting motor threshold, motor evoked potential amplitude, cortical silent period duration, short‐interval intracortical inhibition, intracortical facilitation, long‐interval intracortical inhibition and short‐latency afferent inhibition were evaluated. Global cognition and executive functions were assessed with screening tests. Attention was measured with computerized tasks. RESULTS: Post COVID‐19 patients reported a mean of 4.9 persistent symptoms, high levels of fatigue, exertion, cognitive difficulties, low levels of well‐being and reduced mental well‐being. Compared to HCs, patients presented higher resting motor thresholds, lower motor evoked potential amplitudes and longer cortical silent periods, concurring with reduced M1 excitability. Long‐interval intracortical inhibition and short‐latency afferent inhibition were also impaired, indicating altered GABA(B)‐ergic and cholinergic neurotransmission. Short‐interval intracortical inhibition and intracortical facilitation were not affected. Patients also showed poorer global cognition and executive functions compared to HCs and a clear impairment in sustained and executive attention. CONCLUSIONS: Patients with fatigue and cognitive difficulties following mild COVID‐19 present altered excitability and neurotransmission within M1 and deficits in executive functions and attention. NEUROLOGICAL SEQUELAE OF MILD COVID-19 With an epochal research effort, the biology of SARS-CoV-2 has been unveiled and effective and safe vaccines have been developed. Despite these advancements, crucial issues remain unsolved, and many questions about the nature of some long-term infectionrelated symptoms have not yet been clarified. In particular, little is known about two cardinal symptoms affecting many individuals who recovered from even mild COVID-19 [1, 2] : perceived fatigue and cognitive difficulties [3, 4] . Perceived fatigue following SARS-CoV-2 infection is more pronounced than in the general population [5] . Indeed, these individuals generally report to not feeling fully recuperated despite being deemed medically recovered from the primary illness [5] . Most interestingly, fatigue has been not correlated with initial COVID-19 severity [5] . The high rate of patients complaining of cognitive difficulties and fatigue raises the question whether these symptoms might represent a mild form of post COVID-19 encephalopathy [6] . Dysfunction of executive attention in patients who suffered from severe COVID-19 with neurological complications have been demonstrated previously [7] . In parallel, transcranial magnetic stimulation (TMS) studies showed lack of physiological inhibition of the corticospinal system expected after a fatiguing task, together with a strong impairment of GABAergic interneuronal activity within the primary motor cortex (M1) [7, 8] . A further study on hospitalized COVID-19 patients with neurological manifestations confirmed an impairment of frontoparietal cognitive functions and frontoparietal hypometabolism by 18 F-fluoro-2-deoxyd-glucose positron emission tomography [9] . Notably, hypometabolism of frontal regions, including the olfactory gyrus, has also been identified as a hallmark of post COVID-19 syndrome [10, 11] . In line with our previous findings on severe in this study the aim was to investigate whether abnormal motor cortex physiology and deficits in executive attention could be found also in patients complaining of persisting fatigue and cognitive difficulties following mild SARS-CoV-2 infection. For this purpose, the focus was on the neurophysiological evaluation of excitability and neurotransmission within M1 and on neuropsychological assessment of frontal lobe cognitive functions. The study was conducted at the 'Post COVID' outpatient clinic of the Patients were requested to complete a 16-item questionnaire, modified from a previous study [12] , to explore whether and which symptoms were present at the time of evaluation. Furthermore, patients were specifically asked to report whether anosmia and/or ageusia had occurred at any time during the disease course, which could indicate central nervous system involvement. To evaluate the impact of post COVID-19 syndrome on perceived well-being, participants were asked to rate their 'own health state in the last week' on a Likert scale, ranging from 0 (worst health state) to 100 (best health state). Finally, to assess Sterzing, Italy. Email: paola.ortelli@sabes.it This work was supported by Südtiroler Sanitätsbetrieb-Azienda Sanitaria dell'Alto Adige (SABES-ASDAA) (grants 1767_2020 and 997_2021). cognitive difficulties, executive functions, fatigue, mild COVID-19, primary motor cortex, transcranial magnetic stimulation the affective condition, the Beck Depression Inventory (BDI-II) [13] , a 21-item self-report rating inventory, was administered: participants were asked to rate each item according to symptom severity. (1, strongly disagree; 7, strongly agree) [14] . Concerning FRS, participants were asked to rate fatigue on a numerical rating scale (0, no fatigue; 10, extreme fatigue) [15] . Perceived exertion was assessed using a pinching task of 1 min duration, in which patients and HCs were asked to squeeze a dynamometer (Jamar, Patterson Medical) between the thumb and index finger of their dominant hand as strongly as possible. Participants were verbally encouraged to provide maximum contraction during the whole minute. During the task, participants sat comfortably on a chair with their arms adducted and elbow flexed at 90°. Maximum pinch strength (kg) obtained during 1 min was considered. At the end of the sustained pinching task, participants were asked to report their level of perceived exertion using the Borg Category Ratio (CR100) scale [16] . This scale ranges from 0 to 100 (0, nothing at all; 100, extremely strong). The number 100 implies an extremely strong perceived intensity, that is, the strongest exertion a person has ever experienced. Data obtained were also used to quantify the maximal force produced during the pinching task of both patients and HCs (measured in kilograms). Patients were asked to describe their cognitive difficulties in daily living by referring to one or more of the following: forgetfulness, cloudiness, difficulty focusing, thinking and communicating. To evaluate the severity of them, patients were asked to rate their per- The detailed description of the neurophysiological evaluation is provided in Appendix S1. The detailed description of the neuropsychological evaluation is provided in Appendix S1. The central tendency and dispersion of continuous variables are reported as mean and standard deviation (SD) for demographical, clinical and neuropsychological data; as mean and standard error (SE) for neurophysiological outcomes. Due to violations to the normality as- Relevant associations between couples of variables were assessed by Spearman's correlation coefficient ρ. All statistical tests were two-tailed and statistical significance was set at p < 0.05. To deal with multiple comparisons, the Benjamini-Hochberg method was used, controlling the false discovery rate at 5%. All analyses were carried out using the SAS/STAT statistical package, release 9.4 (SAS Institute Inc.). Demographic and clinical data of post COVID-19 patients are depicted in Table 1 . A prevalence of women (74.6%) characterizes our sample. Eighty-eight per cent of patients were less than 65 years old and 97.0% were right-handed. Patients did not differ significantly from HCs in age, education and gender. The average time from onset (the elapsed interval between COVID-19 infection and study enrolment) was 109.4 (77.5) days, with 10.4% of cases exceeding 6 months since the infection. No associations emerged between the time elapsed from disease onset and the neuropsychological and/or neurophysiological variables (see Table S1 in Appendix S1). Results are shown in Table 1 . Cognitive difficulties were reported by 92.5% of patients, 86.4% complained of fatigue and 77.0% reported both symptoms. During the entire disease course, 85.1% of patients suffered from anosmia (72.7%) and/or ageusia (75.8%). In 25.4% of cases one of these symptoms persisted until the study inclusion. A mean of 4.9 (2.5) symptoms was reported in the post COVID-19 patients' group. In the 100-point Likert well-being rating scale, patients reported significantly lower scores in comparison with HCs. BDI-II showed significantly higher scores in patients than in HCs. To investigate the determinants of the observed values of the BDI-II score in post COVID-19 patients, the relative contribution of each item was assessed. 'Loss of energy', 'changes in sleep', 'concentration difficulty' and 'tiredness or fatigue' were the strongest determinants of total score in comparison with all the others: these items accounted for 42.3% ± 15.5% of total BDI-II score, in comparison with an expected 23% (p < 0.0001). Coherently, both self-evaluation scales measuring perceived fatigue, FRS and FSS, revealed significantly higher scores in patients with post COVID-19 syndrome than in HCs. All patients and HCs completed the 1-min pinching task. The mean produced maximum force in the pinching task was no different between patients and HCs. However, the perceived exertion, expressed as a CR100 score, was significantly higher in patients compared to HCs. All neurophysiological results are reported in Table 2 and in part illustrated in Figures 1 and 2 . Compound muscle action potential onset latency, compound muscle action potential baseline-to-peak amplitude, minimum Fwave latency, F-wave persistence and baseline-to-peak amplitude of the sensory nerve action potential recorded from the digital branches of the fifth finger (D5) did not differ significantly between patients and HCs. Resting motor threshold (RMT) was significantly higher in patients. Nine patients presented very high RMTs (between 86% and Correlation analysis between LICI 100 and SAI 20 values in patients revealed a negative association (ρ = −0.27, p < 0.05). The results are shown in Table 3 . This study provides evidence for abnormal motor cortex physiol- In these patients, both perceived fatigue and exertion were altered. FRS and FSS scores indicated that patients who recovered from mild COVID-19 could still perceive clinically significant fatigue in daily life for a long time after the acute illness, with mean FSS scores extensively higher than normal cut-off values [14] . Concurrently, CR100 showed exaggerated higher perception of physical exertion compared to HCs, despite no differences in exerted force. Mean RMTs (the minimum magnetic stimulation intensity required to transcranially activate M1) were significantly higher in post COVID-19 patients than in HCs; remarkably, nine out of 67 patients presented such high RMTs that they did not undergo further TMS tests, which would have required stimulation intensities higher than MSO. RMTs can reflect excitability of both cortical M1 neurons and spinal motor neurons [19] and can be affected by pathology of the peripheral nervous system [20, 21] . Mean MEP amplitudes were also smaller in patients. Since they did not present corticospinal tract or neuromuscular dysfunction, as previously been reported in other medical conditions with definite brain involvement, for example stroke and multiple sclerosis [22, 23] . A model to explain fatigue in neurological diseases suggests that suppression of the excitatory system and not over-activity of the inhibitory system may lead to the development of fatigue [22, 24] . The motor cortex has strong anatomical connections with other cortical and subcortical regions such as the pre-motor cortices, supplementary motor areas, cingulate motor areas, basal ganglia and the cerebellum [25] [26] [27] which can modulate motor cortex excitability. Inadequate input from brain regions upstream of M1 or reduced excitability of the motor cortex could cause suboptimal neural drive to the α-motor neurons and thus reduced activation of muscle fibres, thus contributing to the genesis of central fatigue. The cortical SP, that is, the transient suppression of voluntary muscle activity following a TMS-evoked motor response during tonic contraction of the target muscle [28] , was longer in patients than in HCs. Although the initial part of the SP is due to spinal inhibitory mechanisms, it largely results from activation of GABA B inhibitory cortical interneurons projecting onto the pyramidal cells [28, 29] . As the SP duration is known to increase with higher stimulation intensities [30] , it is possible that longer SPs are simply due to higher RMTs in patients, which consequently require higher stimulation intensities to elicit MEPs. However, prolonged SPs have been reported in patients with fatigue in multiple sclerosis and stroke [31, 32] and in healthy subjects after mentally fatiguing tasks [33] . In a recent study, patients with fatigue and dysexecutive syndrome after severe COVID-19 presented with reduced activity of GABAergic and cholinergic circuits in M1, as demonstrated by alterations in SICI, LICI and SAI [8] . Therefore, a search was made for alterations of the same neurophysiological markers in the present sample of patients after mild COVID-19. A clear impairment of LICI 100 circuits that index GABA B -ergic interneuronal activity was found [34] , but none in the GABA A -ergic neurotransmission (SICI 2 did not differ significantly between patients and HCs). SICI is affected by chronic hypoxia [35] and its alteration in patients with cognitive impairment and fatigue after severe COVID-19 could have been due to prolonged hypoxia [8] . Examples of cortical silent period in patients and healthy controls. Representative traces of cortical silent period evoked in the first dorsal interosseous muscle of two patients and two HCs at 130% RMT intensity 30% during self-estimated 50% maximum voluntary contraction. Two superimposed traces are presented for each subject Intracortical facilitation tested at ISI 15 ms (ICF 15), which reflects mainly excitatory glutamatergic transmission through the Nmethyld-aspartate receptors, did not differ between patients and HCs, in line with previous findings [8] . GABA is the principal inhibitory neurotransmitter in the human nervous system and plays a fundamental role in neuronal coding and processing. Maladaptation of cortical processes related to degeneration of intracortical inhibitory GABAergic circuits within M1 has been implicated with central fatigue in various affections of the central nervous system [36] [37] [38] . Furthermore, different cognitive abilities, mainly executive functions, are sensitive to cerebral GABA concentrations in the frontal cortex [39, 40] . Altered GABA neurotransmission has been implicated in frontotemporal dementia, in which impairment of executive functions is a prominent feature [41] [42] [43] [44] . As both mechanisms are mediated by GABA B interneurons, SP and LICI should change accordingly; therefore our results of prolonged SP and diminished LICI in patients seem contradictory. A first consideration is that SP is measured during a tonic voluntary contraction and can therefore be influenced by the level of contraction and by afferent inhibition mechanisms [45] , whilst LICI is measured at rest. Furthermore, although SP and LICI are both GABA B -mediated, SP duration is dose-dependent to the administration of GABA Bselective agonists [46] , whilst LICI becomes saturated at low GABA levels [47] , suggesting that SP and LICI can behave differently based on the GABA level in the synaptic cleft. The amount of GABA can be autoregulated by presynaptic GABA B autoreceptors. At any rate, a definite explanation cannot be inferred from the present findings. Compared to HCs, SAI 20 mechanisms were also impaired in patients. SAI is a marker of motor cortex inhibition induced by sensory afferents through inhibitory connections from the primary somatosensory cortex to M1 [48] . This inhibitory sensorimotor integration is under excitatory modulation of cholinergic projections [49, 50] . Abnormal SAI findings concurring with central cholinergic dysfunction are a recognized biomarker of Alzheimer's disease from prodromal stages [41, 51] . were significantly longer than those in HCs, in all conditions. More interestingly, the interference suppression capability was significantly lower in patients than HCs. This deficit was also confirmed by the significant slowing of the patients' response time in those conditions of the Stroop and Navon Task, which reflect the ability to inhibit inappropriate or irrelevant responses, to monitor conflicts and to evaluate stimuli or resource allocation [53] . Taken together, these data confirm previous findings [17, 18] and disclose an impairment of A limitation of this study consists in the lack of a control group of patients who previously suffered from COVID-19 without complaining of fatigue and/or cognitive difficulties. Another limitation is the relatively low number of HCs. Moreover, the investigation of further ISIs in the paired-pulse TMS tests could have provided more information on intracortical circuit activity. This study highlights for the first time that patients with fatigue and cognitive difficulties following mild COVID-19 present abnormal motor cortex neurophysiological findings. The neuropsychological examination unveils the presence of executive-attentive deficits even in these otherwise mildly affected patients. Annelies Gruber is acknowledged for her excellent secretarial support. The authors report no competing interests. writing-review and editing (equal). The data that support the findings of this study are available on request from the corresponding author. The data are not publicly available due to privacy or ethical restrictions. Ortelli https://orcid.org/0000-0002-4005-0235 The road to addressing long COVID Long COVIDmechanisms, risk factors, and management Persistent symptoms after COVID-19: qualitative study of 114 'long COVID' patients and draft quality principles for services Persistent neurologic symptoms and cognitive dysfunction in non-hospitalized COVID-19 'long haulers Persistent fatigue following SARS-CoV-2 infection is common and independent of severity of initial infection Frequent neurologic manifestations and encephalopathy-associated morbidity in COVID-19 patients Neuropsychological and neurophysiological correlates of fatigue in post-acute patients with neurological manifestations of COVID-19: insights into a challenging symptom Intracortical GABAergic dysfunction in patients with fatigue and dysexecutive syndrome after COVID-19 Cognitive impairment and altered cerebral glucose metabolism in the subacute stage of COVID-19 18)F-FDG brain PET hypometabolism in patients with long COVID Long COVID hallmarks on [18F]FDG-PET/CT: a case-control study Persistent symptoms in patients after acute COVID-19 Beck Depression Inventory: manual Fatigue in multiple sclerosis Fatigue in multiple sclerosis: general and perceived fatigue does not depend on corticospinal tract dysfunction A comparison of AME and CR100 for scaling perceived exertion Neurologic features in severe SARS-CoV-2 infection Assessment of cognitive function in patients after COVID-19 infection Stimulation of the human motor cortex through the scalp Cortical involvement in myopathies: insights from transcranial magnetic stimulation Cortical excitability and neurology: insights into the pathophysiology Post-stroke fatigue: a deficit in corticomotor excitability? Sural sparing in Guillain-Barré ® syndrome subtypes: a reappraisal with historical and recent definitions Supraspinal regulation of physical fatigue Motor areas of the medial wall: a review of their location and functional activation A role of the basal ganglia and midbrain nuclei for initiation of motor sequences Parallel organization of functionally segregated circuits linking basal ganglia and cortex Mechanism of the silent period following transcranial magnetic stimulation. Evidence from epidural recordings Silent period evoked by transcranial stimulation of the human cortex and cervicomedullary junction The cortical silent period: intrinsic variability and relation to the waveform of the transcranial magnetic stimulation pulse Prolonged cortical silent period is related to poor fitness and fatigue, but not tumor necrosis factor, in multiple sclerosis Perspective on neuromuscular factors in poststroke fatigue The effect of mental fatigue on neuromuscular function is similar in young and older women TMS and drugs revisited 2014 Functional involvement of central nervous system in acute exacerbation of chronic obstructive pulmonary disease. A preliminary transcranial magnetic stimulation study Motor cortex excitability and fatigue in multiple sclerosis: a transcranial magnetic stimulation study Central nervous system dysfunction in primary biliary cirrhosis and its relationship to symptoms Maladaptation of cortical circuits underlies fatigue and weakness in ALS More GABA, less distraction: a neurochemical predictor of motor decision speed Frontal gamma-aminobutyric acid concentrations are associated with cognitive performance in older adults Classification accuracy of transcranial magnetic stimulation for the diagnosis of neurodegenerative dementias Transcranial magnetic stimulation distinguishes Alzheimer disease from frontotemporal dementia Classification accuracy of TMS for the diagnosis of mild cognitive impairment Effects of palmitoylethanolamide combined with luteoline on frontal lobe functions, high frequency oscillations, and GABAergic transmission in patients with frontotemporal dementia Interactions between inhibitory and excitatory circuits in the human motor cortex The role of GABA B receptors in intracortical inhibition in the human motor cortex Differential effects on motorcortical inhibition induced by blockade of GABA uptake in humans Short latency inhibition of human hand motor cortex by somatosensory input from the hand Interactions between short-interval intracortical inhibition and short-latency afferent inhibition in human motor cortex Muscarinic receptor blockade has differential effects on the excitability of intracortical circuits in the human motor cortex Interactions between beta-amyloid and central cholinergic neurons: implications for Alzheimer's disease What do verbal fluency tasks measure? Predictors of verbal fluency performance in older adults The impairing effects of mental fatigue on response inhibition: an ERP study Cognitive control and attentional functions The attention system of the human brain: 20 years after Volume change in frontal cholinergic structures after traumatic brain injury and cognitive outcome Brain MRI findings in patients in the intensive care unit with COVID-19 infection Neurologic and neuroimaging findings in patients with COVID-19: a retrospective multicenter study Systematic review of EEG findings in 617 patients diagnosed with COVID-19 FDG PET/CT scan reveals hypoactive orbitofrontal cortex in anosmia of COVID-19 Olfactory transmucosal SARS-CoV-2 invasion as a port of central nervous system entry in individuals with COVID-19 Altered motor cortex physiology and dysexecutive syndrome in patients with fatigue and cognitive difficulties after mild COVID-19